NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioXtreme

BioXtreme

Private
IsraelHealthcare & Life Scienceshttps://www.bioxtremerobotics.com/

Last Round

Strategic

Apr 21, 2026

Total Funding Raised

$14.57M

Company Overview

BioXtreme is a medical device company that develops robotic rehabilitation systems for patients recovering from strokes, traumatic brain injuries, and other neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

robotic rehabilitationmedical roboticsrehab roboticsphysical therapy equipmentmotor recoveryneurological rehabilitationsensor-guided therapyrehab techmedical device manufacturererror augmentationassistive roboticshealth IoTrehab automationorthopedic rehabilitationclinical robotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioXtreme Comparables

Compare BioXtreme with similar companies based on industry and business-model similarity.

BioXtreme comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bionik Laboratories Corp.
81%
DIH Medical
81%
Bioness Medical, Inc.
77%

BioXtreme Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 21, 2026
CrowdfundingSep 1, 2023
VC RoundAug 1, 2019
SeedNov 1, 2011
AcceleratorMay 1, 2010

BioXtreme Investors

Notable investors and investment history

BioXtreme investors
InvestorRounds
Israel Innovation AuthoritySeed
ExitValleyCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2010

    $70K raised in Accelerator round.

BioXtreme Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioXtreme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioXtreme's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Year Founded2010
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.